SRS Advogados has assisted Basinnov (Laboratórios Basi – FHC group) in its recent €2M investment in Targtex.
Targtex is a start-up company that develops a new local therapy for the treatment of Glioblastoma (GBM), brain cancer.
SRS Advogados team was led by Paulo Bandeira (Partner – Startups & Venture Capital), Ana Menéres (Partner, Life Sciences) and Solange Fernandes (Associate – Startups & Venture Capital) and included several lawyers and departments of SRS.
